Table 1.
Microbial organisms, interventions, and visual outcome
| S. No. | Eye | Organism | Surgery to symptoms (days) | Presenting visual acuity | Primary intervention | No. of interventions | Secondary intervention and intravitreal antibiotics | IOL explant | Duration of treatment (weeks) | Final BCVA |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
OS |
Pseudomonas aeruginosa |
11 |
20/600 |
PPV + IOA |
6 |
C + IOLex |
Yes |
12 |
20/100 |
| 2 |
OD |
Pseudomonas aeruginosa |
9 |
LP |
PPV + IOA |
1 |
None |
No |
8 |
20/100 |
| 3 |
OD |
Enterobacter |
11 |
LP |
PPV + IOA + IOLex |
1 |
None |
Yes |
1 |
LP |
| 4 |
OS |
Enterobacter |
2 |
LP |
PPV + IOA + IOLex |
2 |
Imip |
Yes |
16 |
20/40 |
| 5 |
OD |
Pseudomonas aeruginosa |
5 |
LP |
PPV + IOA + IOLex |
2 |
Imip |
Yes |
12 |
20/100 |
| 6 |
OS |
Haemophilus |
1 |
20/80 |
PPV + IOA |
2 |
Chlor |
No |
1 |
HM+ |
| 7 |
OS |
Pseudomonas aeruginosa |
14 |
LP |
PPV + IOA |
2 |
PPV |
No |
8 |
HM+ |
| 8 |
OD |
Enterobacter |
5 |
LP |
PPV + IOA |
1 |
None |
No |
8 |
LP |
| 9 |
OS |
Pseudomonas aeruginosa |
14 |
LP |
PPV + IOA + IOLex |
2 |
C + D |
Yes |
1 |
LP |
| 10 |
OD |
Pseudomonas aeruginosa |
7 |
LP |
PPV + IOA |
9 |
Imip + IOLex |
Yes |
12 |
HM+ |
| 11 |
OD |
Pseudomonas aeruginosa |
8 |
LP |
PPV + IOA |
2 |
C + D |
No |
2 |
LP |
| 12 | OD | Pseudomonas aeruginosa | 10 | LP | PPV + IOA | 4 | Imip + D | No | 16 | 20/120 |
In patients with acute postoperative Gram-negative endophthalmitis resistant to both ceftazidime and amikacin. PPV, pars plana vitrectomy; IOA intraocular antibiotic; Imip, imipenem; C, ciprofloxacin; D, dexamathasone; Chlor, chloremphenicol; IOLex, intraocular lens explantation; LP, light perception; HM, hand motion; BCVA, best-corrected visual acuity.